Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.26.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.26.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.10.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.10.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.10.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.10.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XAY.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XAY.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAY.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAY.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CY.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CY.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CY.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBTORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBTENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBTENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBTNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.33ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.33ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.33NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.29ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.29ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.29NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.28ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.1.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.28NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CL.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CL.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CL.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CL.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BM.1.1.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BM.1.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.1.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.1.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBMORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBMENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBMENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBMNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used